APA (7th ed.) Citation

S, N., A, J., A, M., N, P., S, N., N, H., . . . P, P. (2023). Immunogenicity of a fractional or full third dose of AZD1222 vaccine or BNT162b2 messenger RNA vaccine after two doses of CoronaVac vaccines against the Delta and Omicron variants. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 129, 19. https://doi.org/10.1016/j.ijid.2023.01.022

Chicago Style (17th ed.) Citation

S, Niyomnaitham, et al. "Immunogenicity of a Fractional or Full Third Dose of AZD1222 Vaccine or BNT162b2 Messenger RNA Vaccine After Two Doses of CoronaVac Vaccines Against the Delta and Omicron Variants." International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases 129 (2023): 19. https://doi.org/10.1016/j.ijid.2023.01.022.

MLA (9th ed.) Citation

S, Niyomnaitham, et al. "Immunogenicity of a Fractional or Full Third Dose of AZD1222 Vaccine or BNT162b2 Messenger RNA Vaccine After Two Doses of CoronaVac Vaccines Against the Delta and Omicron Variants." International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases, vol. 129, 2023, p. 19, https://doi.org/10.1016/j.ijid.2023.01.022.